Cargando…
Design and Engineering of Deimmunized Vaccinia Viral Vectors
Vaccinia viral (VV) vectors are increasingly used in oncolytic virus therapy and vaccine development for cancer and infectious diseases. However, their effectiveness is hindered by the strong anti-viral immune response induced by the viral vector. In this review, we discuss the strategies to deimmun...
Autores principales: | Song, Kevin, Viskovska, Mariya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697509/ https://www.ncbi.nlm.nih.gov/pubmed/33187060 http://dx.doi.org/10.3390/biomedicines8110491 |
Ejemplares similares
-
New p35 (H3L) Epitope Involved in Vaccinia Virus Neutralization and Its Deimmunization
por: Khlusevich, Yana, et al.
Publicado: (2022) -
Optimization algorithms for functional deimmunization of therapeutic proteins
por: Parker, Andrew S, et al.
Publicado: (2010) -
Mapping the Pareto Optimal Design Space for a Functionally Deimmunized Biotherapeutic Candidate
por: Salvat, Regina S., et al.
Publicado: (2015) -
Vaccinia Virus: From Crude Smallpox Vaccines to Elaborate Viral Vector Vaccine Design
por: Kaynarcalidan, Onur, et al.
Publicado: (2021) -
Deimmunization of flagellin for repeated administration as a vaccine adjuvant
por: Khim, Koemchhoy, et al.
Publicado: (2021)